This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Apr;46(2):65-66.

doi: 10.1159/000499351. Epub 2019 Mar 14.

Infectious Screening of Blood Components: Is There Still a Need for Further Inventions?

Jens Dreier¹, Tanja Vollmer¹

Affiliations

PMID: 31191191
PMCID: PMC6514485
DOI: 10.1159/000499351

Editorial

Infectious Screening of Blood Components: Is There Still a Need for Further Inventions?

Jens Dreier et al. Transfus Med Hemother. 2019 Apr.

. 2019 Apr;46(2):65-66.

doi: 10.1159/000499351. Epub 2019 Mar 14.

Authors

Jens Dreier¹, Tanja Vollmer¹

Affiliation

¹ Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Germany.

PMID: 31191191
PMCID: PMC6514485
DOI: 10.1159/000499351

No abstract available

PubMed Disclaimer

Similar articles

THE PATENTABILITY OF BIOTECHNOLOGICAL INVENTIONS IN THE EU: AN IMPACT ON THERAPEUTIC PRACTICE.
Komarova TV. Komarova TV. Wiad Lek. 2020;73(8):1747-1751. Wiad Lek. 2020. PMID: 33055345
From innovation to infection prevention.
Kao LS, Thomas EJ, Etchegaray JM. Kao LS, et al. Am J Infect Control. 2016 Apr 1;44(4):477-9. doi: 10.1016/j.ajic.2015.10.028. Epub 2016 Jan 5. Am J Infect Control. 2016. PMID: 26775933 No abstract available.
Quantitative identification of technological paradigm changes using knowledge persistence.
Mun C, Yoon S, Kim Y, Raghavan N, Park H. Mun C, et al. PLoS One. 2019 Aug 15;14(8):e0220819. doi: 10.1371/journal.pone.0220819. eCollection 2019. PLoS One. 2019. PMID: 31415621 Free PMC article.
The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions' Patentability.
Althabhawi NM, Zainol ZA. Althabhawi NM, et al. Biomolecules. 2022 Jan 12;12(1):124. doi: 10.3390/biom12010124. Biomolecules. 2022. PMID: 35053272 Free PMC article. Review.
[Personalised COPD care: Where are we going?].
Roche N, Martin C, Burgel PR. Roche N, et al. Rev Pneumol Clin. 2018 Oct;74(5):315-326. doi: 10.1016/j.pneumo.2018.09.003. Epub 2018 Oct 11. Rev Pneumol Clin. 2018. PMID: 30316649 Review. French.

See all similar articles

References

1. Roth WK. History and future of NAT blood donor testing. Transfus Med Hemother. 2019 DOI: XXXX. - PMC - PubMed
1. Stolz M, Gowland P, Tinguely C, Niederhauser C. Safe testing algorithm for individual donation nucleic acid testing (ID-NAT): 10 years' experience in a low prevalence country. Transfus Med Hemother. 2019 DOI: XXXX. - PMC - PubMed
1. Boland F, Martinez A, Pomeroy L, O'Flaherty N. Blood donor screening for hepatitis E virus in the European Union. Transfus Med Hemother. 2019 DOI: XXXX. - PMC - PubMed
1. Prax M, Bekeredjian-Ding I, Krut O. Microbiological screening of platelet concentrates in Europe. Transfus Med Hemother. 2019 DOI: XXXX. - PMC - PubMed
1. Vollmer T, Hinse H, Jürgen Diekmann J, Knabbe C, Dreier J. Extension of the storage period of platelet concentrates in Germany to 5 days by bacterial testing: is it worth the effort? Transfus Med Hemother. 2019 DOI: XXXX. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources